OncBioMune Pharmaceuticals, Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by DIETRICH Constantin, was filed 21 May 2015.
OncBioMune Pharmaceuticals, Inc: what insiders have been doing
OncBioMune Pharmaceuticals, Inc is a listed company. Its directors and officers file their transactions with SEC (Form 4). Nothing new has been filed by managers of OncBioMune Pharmaceuticals, Inc in twelve months, the latest record being from 8 May 2020.
Since 2008, the database holds 8 purchases and 10 sales by insiders of the company.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2023FY ended September 2023 · cache
- 283,334 shares@ US$0.06100.0% of flowShares of Common StockSEC:0001493152-20-008105:0
- 166,667 shares@ US$0.0690.9% of flowShares of Common StockSEC:0001493152-20-008101:0
- 500,000 sharesSeries A Preferred StockSEC:0001493152-19-003370:0
- 60,000 sharesCommon StockSEC:0001493152-17-004211:0
- 2,892,000 sharesSeries B Preferred StockSEC:0001493152-17-004208:0
- 2,892,000 sharesSeries B Preferred StockSEC:0001493152-17-002372:0
- 60,000 shares0Common StockSEC:0001493152-16-007535:0
- 1,025,000 shares@ US$0.001100.0% of flowCommon stockSEC:0001493152-16-007167:1
- 17,951,079 sharesCommon stockSEC:0001493152-16-007166:0
- 1,025,000 shares@ US$0.001100.0% of flowCommon stockSEC:0001493152-16-007166:1
- 17,951,078 sharesCommon stockSEC:0001493152-16-007167:0
- 5,000,000 sharesCommon stockSEC:0001493152-16-007162:0
- 60,000 shares0Common StockSEC:0001493152-15-005724:0
- 666,666 shares0Common StockSEC:0001493152-15-004343:0
- 666,666 shares0Common StockSEC:0001493152-15-004345:0
- 17,774,136 sharesCommon StockSEC:0001493152-15-002663:0
- 17,774,136 sharesCommon StockSEC:0001493152-15-002665:0
- 3,188,546 shares@ US$0.003Common StockSEC:0001493152-15-002665:1
- 17,774,136 sharesCommon StockSEC:0001493152-15-002206:0Canonical exit: 16 Aug 2015 (T+90)
- 17,774,136 sharesCommon StockSEC:0001493152-15-002206:1Canonical exit: 16 Aug 2015 (T+90)
- 17,774,136 sharesCommon StockSEC:0001493152-15-001522:0
- 17,774,136 sharesCommon StockSEC:0001493152-15-001522:1
- 17,774,136 sharesCommon StockSEC:0001493152-15-001503:0Canonical exit: 13 Jul 2015 (T+90)
- 17,774,136 sharesCommon StockSEC:0001493152-15-001503:1Canonical exit: 13 Jul 2015 (T+90)
- 2,100,000 sharesCommon StockSEC:0001493152-15-000867:0
25 of 35 declarations
About OncBioMune Pharmaceuticals, Inc
OncBioMune Pharmaceuticals, Inc is a company focused on developing immunotherapeutic treatments for cancer. It aims to enhance treatment options for patients with various types of cancer.
